I honestly think we have hit the very bottom in this one. There are some big parnerships with some big names and no good drugs on the market for AD as of yet. If the phase III come through with good results and a later FDA approval, this stock could go to $2 in a heart beat very much like TTNP did with their VNDA parnership. One needs to reconsider selling right now and hold for the long term.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.